官方服务：
资源简介：
Summary of Scalp Specific Outcomes of Systemic Therapies for Psoriasis
应用场景：
创建时间：
2025-12-24
相关数据集
Additional file 2 of Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting
Additional File 2: Pairwise difference in Psoriasis Area Severity Index (PASI) from baseline over 12 months receiving Secukinumab among PsO and (PsO-PsA) patients (overall and regarding prior use of b
Figshare2024-08-18 更新40
Supplementary materials for A Phase III Study to Compare Efficacy and Safety of BAT2206 (Proposed Ustekinumab Biosimilar) with Reference Ustekinumab in Patients with Moderate to Severe Plaque Psoriasis
Supplementary tables
Mendeley Data30
Characterizing patients with psoriasis on injectable biologics adalimumab, etanercept, and ustekinumab: A chart review study
Objective: This study examined plaque psoriasis (PsO) patient characteristics across injectable biologics. Methods: Data were collected from 400 US dermatologists randomly selecting five charts each f
Figshare2016-01-20 更新00
Additional file 4 of Development and validation of a psoriasis treatment acceptability measure through group concept mapping
Supplementary Material 4
NIAID Data Ecosystem30
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial
NIAID Data Ecosystem10
